Demlion,
let’s agree on one thing, COVID-19 does not directly kill the patient(the rarity could potentially exist but in 6sigmas it would be the outlier). The disease creates an environment within the host for it to become a perfect incubator because the virus has only two desires, live and reproduce(think of it as a 16-25 year old male). The unfortunate truth is the patients that are dying are a result of their immune system response or lack of response which intern cause the other body systems to fail and ultimately death.
Now your claim about prevention through patient testing, or cure through patient testing; yes you can protect the more fragile if all parties are compliant but that’s a big if and honestly can only be ascertained in a BSL2 or better containment room.
Regarding testing, we need granularity in the statistical reporting, how many infected vs tested, how many of those infected hospitalized for a day, 3 days, week etc. did they require cannulated oxygen, mask, or full intubation and how long of each was required. What were the risk behaviors or factors associated with each pool of statistical patients?
Are you starting to get the idea of the complexity? Testing does not give you a death or survival path. Look at Japan, they’ve run <25,000 tests yet claim less then 50(last a saw) but certainly less than 100 deaths in a population roughly the size of the US. The Philippines is the same story with deeply contrasting lifestyles from Japan.
Do you believe we should use drugs for off label purposes, or plasma antigen therapy?